- Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
-
Kang MJ, Kim MS, Choi EH, Lee KE, Kim YK, Choi HJ
- KMID: 1717999
- Korean J Intern Med.
- 2007 Mar;22(1):63-66.
- doi: 10.3904/kjim.2007.22.1.63
Inhibitors of tumor necrosis factor-alpha (TNF-alpha) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Tuberculous Arthritis Following the Use of Etanercept
-
Choi SW, Ahn JJ, Hwang YT, Koh SH, Cho SD
- KMID: 1776672
- Korean J Intern Med.
- 2009 Dec;24(4):397-401.
- doi: 10.3904/kjim.2009.24.4.397
Etanercept is a tumor necrosis factor (TNF) inhibitor that has been used for the treatment of chronic inflammatory diseases including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Because of its... -
- CITED
-
- Close
- SHARE
-
- Close
- Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
-
Kang MJ, Lee YH, Lee J
- KMID: 1781922
- J Korean Med Sci.
- 2006 Oct;21(5):946-949.
- doi: 10.3346/jkms.2006.21.5.946
Tumor necrosis factor (TNF) is known to play a critical role in the pathogenesis of rheumatoid arthritis (RA). Etanercept is a recombinant soluble fusion protein of TNF type II receptor... -
- CITED
-
- Close
- SHARE
-
- Close
